IN THE NEWS

Pharmaceutical Manufacturing

Ritedose Opens Advanced Laboratory and Expands Analytical Capabilities to Accelerate Pharmaceutical Innovation—Positioning the Company as a Preferred Partner for Drug Development and Manufacturing

– Triples laboratory footprint with the $17 million investment. – Features new leachables and extractables testing capabilities. – Allows for seamless development and manufacturing experience while supporting pharmaceutical products throughout entire lifecycle. – Creates an integrated laboratory infrastructure coupled with…
READ MORE
A smiling scientist in a lab coat, safety glasses, and gloves pours from a reagent bottle into a burette at a laboratory fume hood while a colleague looks on. Overlay text reads "We're investing in the future of pharmaceutical innovation" with the Ritedose logo.

What Ophthalmic Drug Developers Need in a CDMO

Clinical success is only the beginning. For ophthalmic drug developers, the right CDMO can help turn clinical progress into a scalable, sterile, high-quality manufacturing strategy built for commercialization.
READ MORE
Two cartons of YUVEZZI ophthalmic product moving along a conveyor belt in a pharmaceutical manufacturing facility, with a masked worker in the background. Overlay text reads "What do ophthalmic drug developers need in a CDMO?" with the Ritedose logo.
FEATURED NEWS
RECEIVE THE LATEST NEWS

Get a healthy dose of all things Ritedose. Subscribe now for breaking news alerts, updates, previews, and more.

Please enter a valid email address.
TAGS CLOUD

Accessibility